Alpa Laboratories Limited (ALPA.NS)
NSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹51.40 (+6.29%) as of
Key statistics
- Market cap
- 1.08B
- P/E (TTM)
- 30.06
- Forward P/E
- 9.72
- EPS (TTM)
- 1.71
- Dividend yield
- 0.00%
- 52-week range
- 46.10 – 93.85
- Beta
- 0.91
- Revenue (TTM)
- 1.11B
- Profit margin
- 3.82%
- Volume
- 5.61k
About Alpa Laboratories Limited
Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It offers ethical, generic, and over the counter medicines. The company provides tablets, capsules, injections, syrups, ointments, creams, eye drops, and other dosage forms for human and veterinary healthcare, as well as aquaculture products, including probiotics, deodorizer, minerals, feed supplements, and disinfectant. The company was founded in 1967 and is based in Indore, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Indore, India
- Employees
- 457
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.